Please login to the form below

Not currently logged in
Email:
Password:

Y-mAbs Therapeutics

This page shows the latest Y-mAbs Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Y-mAbs files breakthrough neuroblastoma drug in US

Y-mAbs files breakthrough neuroblastoma drug in US

Rare cancer type mostly affects babies and young children. Y-mAbs Therapeutics has filed the first of the two antibody drugs it intends to submit to the FDA, starting with naxitamab ... Y-mAbs reported new results from its main phase 3 naxitamab study at

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics